EP2943507

GENMAB A/S
Application Number
EP14700200A
Filing Date
Jan 9, 2014
Status
Granted And Under Opposition
Jan 24, 2020
Grant Date
Feb 26, 2020
External Links
Slate, Register

Biblio Summary

The patent EP2943507B1 was granted on Feb 26, 2020 by Genmab A/S The patent is currently Granted And Under Opposition.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMPERSAND PARTNERSCHAFT VON RECHANWALTEN MBBNov 26, 2020ADMISSIBLE
MARGARET DIXON LIMITEDNov 25, 2020WITHDRAWN

The table below shows the patents of Genmab A/S that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3319996Bispecific And Multispecific Antibodies And Method For Isolation Of SuchJan 3, 20242
EP3312196Antibodies Against Cd38 For Treatment Of Multiple MyelomaJul 17, 20191
EP2535355Antibodies Against Cd38 For Treatment Of Multiple MyelomaJan 2, 20191